Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma

19 Jul 2021

Abstract excerpt

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers. Developing biomarkers for early detection and chemotherapeutic response prediction is crucial to improve the dismal prognosis of PDAC patients. However, molecular cancer signatures based on transcriptome analysis do not reflect intratumoral heterogeneity. To explore a more accurate stratification of PDAC phenotypes in an easily accessible...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Caveolin-1 and cellular processes
Share to Pancreatic and Hepatic Oncology Research
Share to Pancreatitis Pathology and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34359990
DOI: 10.3390/cells10071821

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal AdenocarcinomaPMID 34359990Read ↗

Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance.Semantic proximity Read ↗

Integrating metabolic profiling of pancreatic juice with transcriptomic analysis of pancreatic cancer tissue identifies distinct clinical subgroupsSemantic proximity Read ↗

Molecular and Metabolic Subtypes Correspondence for Pancreatic Ductal Adenocarcinoma ClassificationSemantic proximity Read ↗

Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)Semantic proximity Read ↗

Metabolomic profiling of pancreatic adenocarcinoma reveals fundamental clinical featuresSemantic proximity Read ↗

Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic predictionSemantic proximity Read ↗

Metabolic and Lipoprotein Profiling of Pancreatic Ductal Adenocarcinoma Patients of African AncestrySemantic proximity Read ↗

Exploring the metabolic landscape of pancreatic ductal adenocarcinoma cells using genome-scale metabolic modelingSemantic proximity Read ↗

Metabolic Syndrome Related Gene Signature Predicts the Prognosis of Patients With Pancreatic Ductal Carcinoma. A Novel Link Between Metabolic Dysregulation and Pancreatic Ductal Carcinoma.Semantic proximity Read ↗

Metabolic Reprogramming：Application of lipid metabolism related genes in the risk model of clinical prognosis of pancreatic cancerSemantic proximity Read ↗

A novel sphingolipid metabolism-related long noncoding RNA signature predicts the prognosis, immune landscape and therapeutic response in pancreatic adenocarcinomaSemantic proximity Read ↗

Exploring the metabolic landscape of pancreatic ductal adenocarcinoma cells using genome-scale metabolic modelingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.